Press Releases
Amgen And Advaxis Enter Global Cancer Immunotherapies Collaboration
Amgen and Advaxis, Inc announced a global agreement for the development and commercialization of Advaxis' ADXS-NEO, a novel, preclinical investigational cancer immunotherapy treatment that is...
Press Releases
Pfizer and Western Oncolytics Announce Immuno-Oncology Research Collaboration to...
Companies plan to advance Western Oncolytics’ lead preclinical therapy into human testingPotential combination of WO-12 with Pfizer’s oncology pipeline could enhance therapeutic benefit in patients....
Press Releases
Economics Drives Thailand led Laboratory Market in ASEAN
Thailand, 2nd largest economy in South East Asia, promotes foreign investment with new S curve structure towards innovative, digital and research based economy, leading the...
Press Releases
Janssen Announces Clinical Collaboration with Bristol-Myers Squibb to Evaluate...
Janssen Biotech, Inc. announced it has entered into a clinical study collaboration agreement with Bristol-Myers Squibb Company to evaluate the combination of two immuno-oncology compounds...
Press Releases
FDA Approves First And Only Single Monthly Injection For...
Amgen announced that the U.S. FDA has approved the Repatha® (evolocumab) Pushtronex™ system (on-body infusor with prefilled cartridge), a new, monthly single-dose administration option.1 ...
Press Releases
EMA accepts Merck’s MAA for cladribine tablets in multiple...
Merck, a leading science and technology company announced that the EMA to request the company for marketing approval for its investigational Cladribine Tablets for the...
Press Releases
Biogen SB5 accepted for review by European Medicines Agency
The Marketing Authorization Application (MAA) for SB5, an adalimumab biosimilar candidate referencing Humira®1, has been accepted for review by the EMA. The MAA for SB5...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.